ACHV
Achieve Life Sciences, Inc.
5.48
USD
This page is just a preview of the data found in TrendSpider’s full version
Achieve Life Sciences, Inc. stock is up 30.79% since 30 days ago. The next earnings date is Mar 14, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 43.75% of the previous 15 December’s closed higher than November. In the last 7 Unusual Options Trades, there were 1 PUT, 6 CALLs.
| Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
|---|---|---|---|---|---|
| 24 Oct 17:23 | 15 Dec, 2023 | 5.00 | 366 | ||
| 16 Nov 15:23 | 15 Mar, 2024 | 2.50 | 148 | ||
| 16 Nov 15:23 | 15 Mar, 2024 | 2.50 | 148 | ||
| 16 Nov 15:24 | 15 Dec, 2023 | 2.50 | 231 | ||
| 16 Nov 18:05 | 15 Mar, 2024 | 2.50 | 148 | ||
| 16 Nov 18:06 | 15 Mar, 2024 | 2.50 | 148 | ||
| 16 Nov 20:58 | 15 Mar, 2024 | 2.50 | 148 |
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company is based in Vancouver, Canada and has license agreements with Sopharma AD and University of Bristol.
